Navigation Links
Cheers to better beer and disease resistance
Date:4/12/2013

For the first time in nearly a century drinkers will be able to taste beer made from Chevallier, the classic heritage barley from the Victorian period.

Old varieties are a rich source of new genes, and scientists at the John Innes Centre revived Chevallier from the institute's Genetic Resources Unit as part of a barley improvement project. Historic records indicate that the variety produced premium quality malt and good yields.

The scientists have received 250,000 of new funding from the Biotechnology and Biological Sciences Research Council to explore the commercial potential of this and other new varieties derived from heritage barleys and to investigate the best growing methods.

"'We wanted to find out how the variety performed, what the malt was like and how the beer tasted," said Dr. Chris Ridout who leads the project.

Dr Ridout and his team revived the variety from seed in JIC's Genetic Resources Unit and started to evaluate its performance. In collaboration with Brewlab and the University of Sunderland, the scientists discovered that Chevallier had valuable disease resistance that can prevent contamination of grain with mycotoxins, which are a concern in the malting industry.

They went on to grow half an acre of the Victorian barley during 2012 at the John Innes Centre, and the grain was then floor-malted by Crisp Malting Group at Great Ryburgh, Norfolk.

"We found that we brought back to life a distinctive malty flavour suited to certain types of beer, such as Porter and India Pale Ale, which were popular in the Victorian period," said Dr Ridout.

"We are now performing genetic analyses which will help us understand how valuable traits such as disease resistance, malting quality and nitrogen use are inherited."

From 19th April, a heritage special bitter made from Chevallier by Stumptail Brewery will be available at the Duke of Wellington pub in Norwich. This nut-brown ale has a rich malty flavour and a lasting bitter finish. It comes with an ABV of 4.7%.

The launch coincides with the AGM of the Campaign for Real Ale (CAMRA) which takes place at St Andrews Hall in Norwich 19th-21st April.

This year, visitors will be able to see Chevallier growing at the Gressenhall Museum of Rural Life in Norfolk, where it will be grown using organic methods. It will also be grown at Morley on land owned by the John Innes Foundation, with modern methods including application of fungicides and nitrogen fertiliser. Differences in yield and the quality of the malt in the two growing regimes will be investigated.

Dr. Ridout has now registered Chevallier as a conservation variety, recently published in the Plant Varieties and Seeds Gazette.


'/>"/>

Contact: Zoe Dunford
zoe.dunford@nbi.ac.uk
07-768-164-185
Norwich BioScience Institutes
Source:Eurekalert

Related biology news :

1. New methods for better purification of wastewater
2. Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
3. UNH researchers find African farmers need better climate change data to improve farming practices
4. Giant squids giant eyes: The better to see hungry whales with
5. Improved loblolly pines better for the environment, study finds
6. Fish larvae find the reef by orienting: The earlier the better
7. Intensive kidney dialysis indicates better survival rates than conventional dialysis
8. Modern hybrid corn makes better use of nitrogen, study shows
9. Bigger gorillas better at attracting mates and raising young
10. Better housing conditions for zebrafish could improve research results
11. Better plants for biofuels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Biometrics Market 2017-2021" report to their offering. ... The global voice recognition biometrics ... 2017-2021. The report covers the present scenario and ... 2017-2021. To calculate the market size, the report considers the revenue ...
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... Arbor, MI (PRWEB) , ... February 16, 2017 , ... ... 5:00-7:00 p.m. The event will be held at Avomeen Analytical Services (4840 Venture ... by a MichBio member organization. They provide an opportunity to interact with peers, make ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
Breaking Biology Technology: